The SELECT Prostate Cancer Prevention Trial
Updated:
08/03/2004
Introduction
NCI Materials
NCI Press Materials
NCI Cancer Information Service Fact Sheets
Other Materials
Current Clinical Trials
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
Quick Links
Dictionary
Funding Opportunities
NCI Publications
NCI Calendar
Español
NCI Highlights
Chemo Extends Life in Advanced Prostate Cancer
Temozolomide Plus Radiation Helps Brain Cancer
Confirmed: Raloxifene Drops Risk of Breast Cancer
Bortezomib Delays Progression of Multiple Myeloma
Annual Report to the Nation
Past Highlights
Related Pages
Prostate Cancer Home Page
NCI's gateway for information about prostate cancer.
NCI Materials
SELECT Data: Enrollment Statistics
(Updated: 09/04/2003) - Enrollment data from SELECT, the Selenium and Vitamin E Cancer Prevention Trial.
Prostate Cancer (PDQ®): Prevention
[ patient ]
[ health professional ]
Expert-reviewed information summary about factors that may influence the risk of developing prostate cancer and about research aimed at the prevention of this disease.
Phase III Randomized Study of Selenium and Vitamin E for the Prevention of Prostate Cancer (SELECT Trial)
A summary of the SELECT protocol statement.
< Previous Section
|
Next Section >
Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Site Help
|
Site Map
A Service of the National Cancer Institute
